Wave Life Sciences Ltd.
WVE
Price:
$7.62
Market Cap:
$1.25B
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional proteins, or modulate protein expression. The company also develops WVE-004, a C9orf72 molecule for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia; WVE-003, a mutant huntingtin SNP3 molecule for the treatment of Huntington's disease; WVE-N531, an Exon 53 molecule for the treatment of Duchenne muscular dystrophy; and ATXN3, a ...[Read more]
Industry
Biotechnology
IPO Date
2015-11-11
Stock Exchange
NASDAQ
Ticker
WVE
PE Ratio
[-11.72]
ROE
[-72.94%]
Current Ratio
[2.51]
Dividend Yield
[0%]
Enterprise Value
[1.07B]
Dividend History
The Enterprise Value as of December 2025 (TTM) for Wave Life Sciences Ltd. (WVE) is 1.07B
According to Wave Life Sciences Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.07B. This represents a change of -9.53% compared to the average of 1.19B of the last 4 quarters.
Wave Life Sciences Ltd. (WVE) Historical Enterprise Value (quarterly & annually)
How has WVE Enterprise Value performed in the past?
The mean historical Enterprise Value of Wave Life Sciences Ltd. over the last ten years is 512.89M. The current 1.07B Enterprise Value has changed 20.83% with respect to the historical average. Over the past ten years (40 quarters), WVE's Enterprise Value was at its highest in in the December 2024 quarter at 1.72B. The Enterprise Value was at its lowest in in the December 2021 quarter at 58.35M.
Average
512.89M
Median
406.79M
Minimum
42.08M
Maximum
1.43B
Wave Life Sciences Ltd. (WVE) Enterprise Value by Quarter and Year
Discovering the peaks and valleys of Wave Life Sciences Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.09%
Maximum Annual Enterprise Value = 1.43B
Minimum Annual Increase = -85.10%
Minimum Annual Enterprise Value = 42.08M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 1.43B | 290.09% |
| 2023 | 367.56M | -26.65% |
| 2022 | 501.11M | 1.09% |
| 2021 | 42.08M | -72.59% |
| 2020 | 153.53M | -2.21% |
| 2019 | 157.00M | -85.10% |
| 2018 | 1.05B | 33.09% |
| 2017 | 791.57M | 77.47% |
| 2016 | 446.02M | 144.17% |
| 2015 | 182.67M | -45.29% |
Wave Life Sciences Ltd. (WVE) Average Enterprise Value
How has WVE Enterprise Value performed in the past?
The current Enterprise Value of Wave Life Sciences Ltd. (WVE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
767.49M
5-year avg
499.62M
10-year avg
512.89M
Wave Life Sciences Ltd. (WVE) Enterprise Value vs. Peers
How is WVE’s Enterprise Value compared to its peers?
Wave Life Sciences Ltd.’s Enterprise Value is less than Precigen, Inc. (1.22B), less than Zenas BioPharma, Inc. (1.55B), less than Upstream Bio, Inc. (1.46B), less than Enliven Therapeutics, Inc. (1.15B), less than Spyre Therapeutics, Inc. (1.96B), greater than ORIC Pharmaceuticals, Inc. (1.06B), less than Terns Pharmaceuticals, Inc. (2.30B), less than Tourmaline Bio, Inc. (1.20B), greater than Intellia Therapeutics, Inc. (925.20M), greater than Amylyx Pharmaceuticals, Inc. (985.24M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.22B | $1.13B | |
| 1.55B | $1.60B | |
| 1.46B | $1.50B | |
| 1.15B | $1.27B | |
| 1.96B | $2.02B | |
| 1.06B | $1.11B | |
| 2.30B | $2.44B | |
| 1.20B | $1.23B | |
| 925.20M | $1.02B | |
| 985.24M | $1.20B |
Build a custom stock screener for Wave Life Sciences Ltd. (WVE) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Wave Life Sciences Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Wave Life Sciences Ltd. (WVE) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Wave Life Sciences Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Wave Life Sciences Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Wave Life Sciences Ltd. (WVE)?
What is the 3-year average Enterprise Value for Wave Life Sciences Ltd. (WVE)?
What is the 5-year average Enterprise Value for Wave Life Sciences Ltd. (WVE)?
How does the current Enterprise Value for Wave Life Sciences Ltd. (WVE) compare to its historical average?